CNTA - Centessa Pharmaceuticals plc

QQQ $ 589.55 $ -22.12 (-3.62 %)

DIA $ 459.89 $ -6.79 (-1.45 %)

SPY $ 656.26 $ -16.64 (-2.47 %)

TLT $ 89.19 $ 0.19 (0.22 %)

GLD $ 375.12 $ -0.13 (-0.03 %)

Previous Close

$ 28

Open

$ 28.79

Bid

$ 27.58 x 82

Ask

$ 27.70 x 2

Day's Range

$ 27.63 - $ 29.32

52 Week Range

$ 9.60 - $ 29.29

Volume

1,477,348

Average Volume

Market Cap

3.76B

Beta (5Y Monthly)

$ 0.52

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-05-2025	09-30-2025	10-Q
2	08-12-2025	06-30-2025	10-Q
3	05-14-2025	03-31-2025	10-Q
4	03-24-2025	12-31-2024	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-13-2024	06-30-2024	10-Q
7	05-13-2024	03-31-2024	10-Q
8	03-28-2024	12-31-2023	10-K
9	11-13-2023	09-30-2023	10-Q
10	08-14-2023	06-30-2023	10-Q
11	05-12-2023	03-31-2023	10-Q
12	03-30-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-10-2022	06-30-2022	10-Q
15	05-16-2022	03-31-2022	10-Q
16	03-30-2022	12-31-2021	10-K
17	11-15-2021	09-30-2021	10-Q
18	08-16-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Guggenheim Maintains Buy on Centessa Pharm...
11/18/2025 14:51:25

Guggenheim analyst Debjit Chattopadhyay maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy and raises the price tar...

Wells Fargo Maintains Overweight on Centes...
11/13/2025 15:45:00

Wells Fargo analyst Benjamin Burnett maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Overweight and raises the price...

Reported Earlier, Centessa Pharmaceuticals...
11/12/2025 07:14:31

Centessa Pharmaceuticals Announces Underwr...
11/11/2025 21:01:02

Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company, today announced that it has commenced an u...

Wells Fargo Maintains Overweight on Centes...
11/07/2025 18:49:30

Wells Fargo analyst Benjamin Burnett maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Overweight and lowers the price...

Centessa Pharmaceuticals' Phase 2a Data1 F...
11/05/2025 12:14:14

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported financial results for the ...

Centessa Pharmaceuticals Q3 EPS $(0.41) Mi...
11/05/2025 12:12:13

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.41) per share which missed the analyst consensus estima...

this-dominos-pizza-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday

This Domino's Pizza Analyst Begins Coverag...
10/28/2025 11:17:33

Stephens & Co. Initiates Coverage On Cente...
10/28/2025 10:10:30

Stephens & Co. analyst Sudan Loganathan initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Overweight r...

12 Health Care Stocks Moving In Monday's A...
10/20/2025 21:08:49

Guggenheim Reiterates Buy on Centessa Phar...
10/06/2025 13:14:31

Guggenheim analyst Debjit Chattopadhyay reiterates Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy and maintains $28 price...

3-biotech-stocks-showing-strength-with-big-spikes-in-momentum-scores

3 Biotech Stocks Showing Strength With Big...
09/12/2025 09:27:00

A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking's Momentum scores.

Wells Fargo Initiates Coverage On Centessa...
09/03/2025 12:41:25

Wells Fargo analyst Benjamin Burnett initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Overweight rating a...

Chardan Capital Maintains Buy on Centessa ...
08/12/2025 20:27:59

Chardan Capital analyst Rudy Li maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy and maintains $30 price target.

Centessa Pharmaceuticals Q2 EPS $(0.38) Mi...
08/12/2025 11:16:17

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.38) per share which missed the analyst consensus estima...

Chardan Capital Maintains Buy on Centessa ...
07/30/2025 22:05:43

Chardan Capital analyst Rudy Li maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy and maintains $30 price target.

Truist Securities Initiates Coverage On Ce...
07/21/2025 11:54:35

Truist Securities analyst Danielle Brill initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy rating and ...

Centessa Pharmaceuticals Receives FDA Clea...
06/16/2025 13:01:30

Needham Initiates Coverage On Centessa Pha...
05/28/2025 10:25:12

Needham analyst Ami Fadia initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy rating and announces Price...

Centessa Pharmaceuticals Q1 EPS $(0.20) Be...
05/14/2025 11:04:14

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate...